These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 10096501)

  • 21. Secondary ion mass spectrometry as a tool for investigating radiopharmaceutical distribution at the cellular level: the example of I-BZA and (14)C-I-BZA.
    Chéhadé F; de Labriolle-Vaylet C; Moins N; Moreau MF; Papon J; Labarre P; Galle P; Veyre A; Hindié E
    J Nucl Med; 2005 Oct; 46(10):1701-6. PubMed ID: 16204721
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Benzamides as melanotropic carriers for radioisotopes, metals, cytotoxic agents and as enzyme inhibitors.
    Oltmanns D; Eisenhut M; Mier W; Haberkorn U
    Curr Med Chem; 2009; 16(17):2086-94. PubMed ID: 19519383
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and evaluation of novel radioiodinated benzamides for malignant melanoma.
    Pham TQ; Greguric I; Liu X; Berghofer P; Ballantyne P; Chapman J; Mattner F; Dikic B; Jackson T; Loc'h C; Katsifis A
    J Med Chem; 2007 Jul; 50(15):3561-72. PubMed ID: 17602544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radioiodinated N-(alkylaminoalkyl)-substituted 4-methoxy-, 4-hydroxy-, and 4-aminobenzamides: biological investigations for the improvement of melanoma-imaging agents.
    Mohammed A; Nicholl C; Titsch U; Eisenhut M
    Nucl Med Biol; 1997 Jul; 24(5):373-80. PubMed ID: 9290070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and evaluation of new iodine-125 radiopharmaceuticals as potential tracers for malignant melanoma.
    Michelot JM; Moreau MF; Labarre PG; Madelmont JC; Veyre AJ; Papon JM; Parry DF; Bonafous JF; Boire JY; Desplanches GG
    J Nucl Med; 1991 Aug; 32(8):1573-80. PubMed ID: 1869982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiopharmaceutical therapy of patients with metastasized melanoma with the melanin-binding benzamide 131I-BA52.
    Mier W; Kratochwil C; Hassel JC; Giesel FL; Beijer B; Babich JW; Friebe M; Eisenhut M; Enk A; Haberkorn U
    J Nucl Med; 2014 Jan; 55(1):9-14. PubMed ID: 24277756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, in vitro pharmacologic characterization, and preclinical evaluation of N-[2-(1'-piperidinyl)ethyl]-3-[125I]iodo-4-methoxybenzamide (P[125I]MBA) for imaging breast cancer.
    John CS; Bowen WD; Fisher SJ; Lim BB; Geyer BC; Vilner BJ; Wahl RL
    Nucl Med Biol; 1999 May; 26(4):377-82. PubMed ID: 10382840
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uptake of [131I]thiouracil in tumours of patients with disseminated malignant melanoma. A pilot study.
    Olander K; Larsson BS; Ringborg U; Schnell PO
    Melanoma Res; 1992; 1(5-6):391-5. PubMed ID: 1422195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting sigma receptor-binding benzamides as in vivo diagnostic and therapeutic agents for human prostate tumors.
    John CS; Vilner BJ; Geyer BC; Moody T; Bowen WD
    Cancer Res; 1999 Sep; 59(18):4578-83. PubMed ID: 10493511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Melanoma-targeting properties of (99m)technetium-labeled cyclic alpha-melanocyte-stimulating hormone peptide analogues.
    Chen J; Cheng Z; Hoffman TJ; Jurisson SS; Quinn TP
    Cancer Res; 2000 Oct; 60(20):5649-58. PubMed ID: 11059756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preparation and biologic evaluation of a novel radioiodinated benzylpiperazine, 123I-MEL037, for malignant melanoma.
    Pham TQ; Berghofer P; Liu X; Greguric I; Dikic B; Ballantyne P; Mattner F; Nguyen V; Loc'h C; Katsifis A
    J Nucl Med; 2007 Aug; 48(8):1348-56. PubMed ID: 17631542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sensitivity versus specificity in melanoma imaging using iodine-123 iodobenzamide and indium-111 pentetreotide.
    Hoefnagel CA; Rankin EM; Valdés Olmos RA; Israëls SP; Pavel S; Janssen AG
    Eur J Nucl Med; 1994 Jun; 21(6):587-8. PubMed ID: 7915988
    [No Abstract]   [Full Text] [Related]  

  • 33. Synthesis, characterization and comparative biodistribution study of a new series of p-iodine-125 benzamides as potential melanoma imaging agents.
    Moins N; Papon J; Seguin H; Gardette D; Moreau MF; Labarre P; Bayle M; Michelot J; Gramain JC; Madelmont JC; Veyre A
    Nucl Med Biol; 2001 Oct; 28(7):799-808. PubMed ID: 11578901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and evaluation of novel radioiodinated nicotinamides for malignant melanoma.
    Liu X; Pham TQ; Berghofer P; Chapman J; Greguric I; Mitchell P; Mattner F; Loc'h C; Katsifis A
    Nucl Med Biol; 2008 Oct; 35(7):769-81. PubMed ID: 18848662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel radiopharmaceutical for detection of malignant melanoma, based on melanin formation: 3-iodo-4-hydroxyphenyl-L-cysteine.
    Nishii R; Kawai K; Garcia Flores L; Kataoka H; Jinnouchi S; Nagamachi S; Arano Y; Tamura S
    Nucl Med Commun; 2003 May; 24(5):575-82. PubMed ID: 12717077
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A malignant melanoma imaging agent: synthesis, characterization, in vitro binding and biodistribution of iodine-125-(2-piperidinylaminoethyl)4-iodobenzamide.
    John CS; Bowen WD; Saga T; Kinuya S; Vilner BJ; Baumgold J; Paik CH; Reba RC; Neumann RD; Varma VM
    J Nucl Med; 1993 Dec; 34(12):2169-75. PubMed ID: 8254405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vivo responses of human A375M melanoma to a σ ligand: 18F-FDG PET imaging.
    Rybczynska AA; de Bruyn M; Ramakrishnan NK; de Jong JR; Elsinga PH; Helfrich W; Dierckx RA; van Waarde A
    J Nucl Med; 2013 Sep; 54(9):1613-20. PubMed ID: 23940303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, in vitro validation and in vivo pharmacokinetics of [125I]N-[2-(4-iodophenyl)ethyl]-N-methyl-2-(1-piperidinyl) ethylamine: a high-affinity ligand for imaging sigma receptor positive tumors.
    John CS; Gulden ME; Vilner BJ; Bowen WD
    Nucl Med Biol; 1996 Aug; 23(6):761-6. PubMed ID: 8940718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Limited sensitivity of iodine-123-2-hydroxy-3-iodo-6-methoxy-N-[(1-ethyl-2-pyrrolidinyl)methyl ] benzamide whole-body scintigraphy in patients with malignant melanoma: a comparison with thallium-201 imaging.
    Brenner W; Klomp HJ; Bohuslavizki KH; Szonn B; Kampen WU; Henze E
    Eur J Nucl Med; 1999 Dec; 26(12):1567-71. PubMed ID: 10638408
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.